IOL CHEMICALS & PHARM. | SUVEN LIFE SCIENCES | IOL CHEMICALS & PHARM./ SUVEN LIFE SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.5 | -22.0 | - | View Chart |
P/BV | x | 1.5 | 6.2 | 24.7% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. SUVEN LIFE SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
SUVEN LIFE SCIENCES Mar-23 |
IOL CHEMICALS & PHARM./ SUVEN LIFE SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 94 | 572.4% | |
Low | Rs | 272 | 45 | 604.8% | |
Sales per share (Unadj.) | Rs | 377.6 | 0.6 | 60,825.3% | |
Earnings per share (Unadj.) | Rs | 23.7 | -5.4 | -437.0% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -5.1 | -616.0% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 17.2 | 1,492.1% | |
Shares outstanding (eoy) | m | 58.71 | 218.07 | 26.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 111.8 | 1.0% | |
Avg P/E ratio | x | 17.1 | -12.8 | -133.4% | |
P/CF ratio (eoy) | x | 12.8 | -13.5 | -94.6% | |
Price / Book Value ratio | x | 1.6 | 4.0 | 39.1% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 15,131 | 156.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 186 | 903.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 135 | 16,375.7% | |
Other income | Rs m | 256 | 84 | 303.1% | |
Total revenues | Rs m | 22,427 | 220 | 10,199.7% | |
Gross profit | Rs m | 2,257 | -1,196 | -188.6% | |
Depreciation | Rs m | 462 | 65 | 705.5% | |
Interest | Rs m | 165 | 5 | 3,061.3% | |
Profit before tax | Rs m | 1,887 | -1,183 | -159.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 0 | - | |
Profit after tax | Rs m | 1,391 | -1,183 | -117.6% | |
Gross profit margin | % | 10.2 | -883.6 | -1.2% | |
Effective tax rate | % | 26.2 | 0 | - | |
Net profit margin | % | 6.3 | -873.5 | -0.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 3,455 | 279.8% | |
Current liabilities | Rs m | 5,025 | 1,050 | 478.5% | |
Net working cap to sales | % | 20.9 | 1,776.0 | 1.2% | |
Current ratio | x | 1.9 | 3.3 | 58.5% | |
Inventory Days | Days | 43 | 3,948 | 1.1% | |
Debtors Days | Days | 8 | 218 | 3.8% | |
Net fixed assets | Rs m | 11,017 | 1,373 | 802.3% | |
Share capital | Rs m | 587 | 218 | 269.2% | |
"Free" reserves | Rs m | 14,490 | 3,535 | 409.9% | |
Net worth | Rs m | 15,077 | 3,753 | 401.7% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 4,828 | 428.4% | |
Interest coverage | x | 12.5 | -218.8 | -5.7% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0 | 3,822.5% | |
Return on assets | % | 7.5 | -24.4 | -30.9% | |
Return on equity | % | 9.2 | -31.5 | -29.3% | |
Return on capital | % | 13.6 | -31.4 | -43.4% | |
Exports to sales | % | 26.7 | 40.4 | 66.1% | |
Imports to sales | % | 0 | 839.8 | 0.0% | |
Exports (fob) | Rs m | 5,930 | 55 | 10,831.2% | |
Imports (cif) | Rs m | NA | 1,137 | 0.0% | |
Fx inflow | Rs m | 5,930 | 55 | 10,831.2% | |
Fx outflow | Rs m | 6,052 | 1,137 | 532.2% | |
Net fx | Rs m | -122 | -1,082 | 11.2% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -1,031 | -118.5% | |
From Investments | Rs m | -1,200 | -2,606 | 46.0% | |
From Financial Activity | Rs m | -41 | 3,955 | -1.0% | |
Net Cashflow | Rs m | -18 | 317 | -5.8% |
Indian Promoters | % | 48.2 | 69.6 | 69.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 1.5 | 112.6% | |
FIIs | % | 1.4 | 0.5 | 304.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 30.4 | 170.3% | |
Shareholders | 130,003 | 68,959 | 188.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Suven Life Sciences | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 1.64% | 0.85% | -0.57% |
1-Month | 4.77% | 8.38% | 0.07% |
1-Year | -0.25% | 90.72% | 52.18% |
3-Year CAGR | -13.23% | 4.10% | 14.04% |
5-Year CAGR | 16.12% | -15.08% | 19.13% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Suven Life Sciences share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Suven Life Sciences the stake stands at 69.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Suven Life Sciences.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Suven Life Sciences paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Suven Life Sciences.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.